Publications
- Tyrosine kinase inhibitors in the first-line treatment for metastatic nonclear cell renal carcinoma: A retrospective analysis of a national database2019 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Pilot study on microRNAs as biomarkers of response to sunitinib treatment in patients with metastatic renal cell carcinoma2018 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Candidate MicroRNA biomarkers of therapeutic response to sunitinib in metastatic renal cell carcinoma: A validation study in patients with extremely good and poor response2018 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Nivolumab induced encephalopathy in a man with metastatic renal celll cancer: a case report2018 | Faculty of Medicine in Hradec Králové
- Current possibilities of immunotherapy in the treatment of malignant melanoma2018 | Faculty of Medicine in Hradec Králové
- Outcomes of Patients With Long-Term Treatment Response to Vascular Endothelial Growth Factor-Targeted Therapy for Metastatic Renal Cell Cancer2017 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Immunoterapy related toxicities2017 | Faculty of Medicine in Hradec Králové
- Dual targeted therapy in patients with malignant melanoma2017 | Faculty of Medicine in Hradec Králové
- The Role of BRAF/MEK Inhibition in Metastatic Malignant Melanoma - a Case Study2016 | Faculty of Medicine in Hradec Králové
- Rapid and clinically significant response to masitinib in the treatment of mucosal primary esophageal melanoma with somatic KIT exon 11 mutation involving brain metastases: A case report2015 | Faculty of Medicine in Hradec Králové
Loading network view...
